Reveleer is a healthcare-focused, technology-driven workflow, data, and analytics company that utilizes natural language processing (NLP) and artificial intelligence (AI) to empower health plans and risk-bearing providers. Founded in 2009 and headquartered in the United States, Reveleer's end-to-end platform offers a wide array of services including Risk Adjustment, Quality Improvement, and Member Management programs. The company's transformative solution allows plans to independently execute and manage every aspect of enrollment, provider outreach, data retrieval, coding, abstraction, reporting, and submissions. By leveraging proprietary technology and robust data sets, Reveleer enables health plans to confidently plan and execute programs for more value and improved outcomes. Reveleer recently secured a significant $65.00M Debt Financing investment on 26 February 2024 from Hercules Capital. This financial backing underscores investor confidence in Reveleer's potential to drive innovation and efficiency within the Health Care, Information Technology, and SaaS industries.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Debt Financing | $65.00M | 1 | 26 Feb 2024 | |
Venture Round | $14.40M | - | 21 Feb 2023 | |
Series D | $46.00M | - | 19 Apr 2022 | |
Venture Round | $65.00M | 3 | 07 Dec 2021 | |
Series C | $5.50M | 2 | 01 Nov 2019 |
No recent news or press coverage available for Reveleer.